MSCLF Stock: Satellos Bioscience Inc. Stock Price, Analysis & Insights
Get live MSCLF stock price $6.25, comprehensive Satellos Bioscience Inc. stock analysis, charts, news, and expert forecast. Real-time MSCLF stock data and investment insights.
Loading chart data...
Satellos Bioscience Inc. (MSCLF) Overview
Satellos Bioscience Inc. (MSCLF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, MSCLF trades at $6.25 with a market capitalization of 96.62M . Over the past 52 weeks, MSCLF has traded between $0.88 and $12.50 , with the current price positioned at approximately 46% of this range . The stock currently tra...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 96.62M
- Current price: $6.25
- 52-week range: $0.88 - $12.50
- P/E ratio: 2.43
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug....
Company Information
- CEO
- Francis Gleeson
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 14
Contact Information
- Website
- https://satellos.com
- Address
- 65 Front Street East
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 2.4)
✓ Lower volatility stock (Beta: 0.71) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Satellos Bioscience Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Satellos Bioscience Inc.
- ⚠Investors should consider how Satellos Bioscience Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
96.62M
P/E Ratio (TTM)
2.43
Beta
0.71
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MSCLF with peer companies:
- Price
- $3.45
- Market cap
- 58.59M
- Price
- $0.00
- Market cap
- 1.18K
- Price
- $0.08
- Market cap
- 34.43M
- Price
- $0.27
- Market cap
- 125.85M
- Price
- $0.14
- Market cap
- 60.07M
- Price
- $0.12
- Market cap
- 81.37M
- Price
- $0.06
- Market cap
- 11.96M
- Price
- $5.10
- Market cap
- 214.67M
- Price
- $0.01
- Market cap
- 101.43M
- Price
- $0.01
- Market cap
- 2.30M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.